You are here: Home / About Us / Quality and Accountability / Peformance Indicators / Patient Safety Indicators / VRE (Vancomycin-resistant enterococci ) Rates
Share:

VRE (Vancomycin-resistant enterococci ) Rates

What is VRE?

Enterococci are germs that live in the gastrointestinal tract (bowels) of most individuals and generally do not cause harm (this is called “colonization”). Enterococci can cause infections in other parts of the body outside the bowel, most commonly urinary tract infections. Vancomycin-resistant enterococci (VRE) are strains of enterococci that are resistant to the antibiotic vancomycin. At Mount Sinai Hospital, we screen patients to detect colonization with VRE regularly, to help prevent VRE infections.


VRE Bacteraemia Rate

  Reporting
Period
Jul. 1-
Sep. 30
2016
Apr. 1-
Jun. 30
2016
Jan. 1-
Mar. 31
2016
Oct. 1-
Dec. 31
2015
Jul. 1-
Sep. 30
2015
Apr 1-
Jun. 30
2015
Jan 1-
Mar. 31
2015
Oct 1-
Dec. 31
2014
Jul 1-
Sep. 30
2014
Apr 1-
Jun. 30
2014
Jan 1-
Mar. 31
2014
Oct 1-
Dec. 31
2013
July 1-
Sep. 30
2013
Apr. 1-
Jun. 30
2013
Jan. 1 -
Mar. 30
2013
Apr. 1 -
Jun. 30
2012
Jul. 1 -
Sep. 30
2012
Oct. 1 -
Dec. 31
2012
Case
count
0 0 0 0 less than 5 0 0 0 0 0 0 0 less than 5 0 0 0 0 less than 5
Rate per
1000 days
0 0 0 0 0.04 0 0 0 0 0 0 0 0.06 0 0 0 0 0.03

What are we doing to prevent VRE?

  • Hand hygiene program
  • Mandatory annual staff education 
  • Screening program to test patients for VRE
  • Programs for patient management to reduce spread of infection such as the use of private room accommodation and additional patient care precautions
  • Ongoing education and monitoring of environmental cleaning practices
  • Participation in national surveillance and research.